2021. Tissue-Engineered “Metastases”: Treatment of Hepatic Colon Tumors with a Dual Action Autotaxin Inhibitor-Lysophosphatidic Acid Receptor Antagonist . Journal of Cancer Research Updates. 1, 1 (Aug. 2021), 69–77. DOI:https://doi.org/10.6000/1929-2279.2012.01.01.11.